[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337871-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337871-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","unveiling-the-role-of-rac3-in-the-growth-and-invasion-of-cisplatin-resistant-bladder-cancer-cells-abstract","Unveiling the role of RAC3 in the growth and invasion of cisplatin-resistant bladder cancer cells - Abstract","","Bladder cancer continues to rise in incidence and deaths worldwide, yet the mechanisms by which RAC family small GTPase 3 (RAC3) regulates cisplatin resistance remain unclear. Bioinformatics assessed RAC3 expression in bladder tissues and evaluated links to grade, stage, distant metastasis, survival, immune microenvironment, genomic mutations, and stemness. Western blotting measured RAC3 in normal and cisplatin-resistant lines, followed by RAC3 overexpression/knockdown and JNK/MAPK modulation to test viability, invasion, and apoptosis in vitro.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/unveiling-the-role-of-rac3-in-the-growth-and-invasion-of-cisplatin-resistant-bladder-cancer-cells-abstract/337871/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/unveiling-the-role-of-rac3-in-the-growth-and-invasion-of-cisplatin-resistant-bladder-cancer-cells-abstract/337871.png","ImageObject",300,407,{"name":42,"@type":43},"Hazel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is RAC3 investigated in cisplatin-resistant bladder cancer?","Question",{"text":63,"@type":64},"RAC3 is a member of Rho GTPases known to influence cancer growth and drug resistance, but its specific regulatory role in cisplatin-resistant bladder cancer cells was previously unclear.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was RAC3 expression analyzed in the study?",{"text":68,"@type":64},"Bioinformatics evaluated RAC3 expression in bladder cancer tissues, and Western blotting detected RAC3 levels in normal bladder cancer cell lines and the cisplatin-resistant BIU-87-DDP line.",{"name":70,"@type":61,"acceptedAnswer":71},"What is the reported effect of altering RAC3 levels on cisplatin-resistant cells?",{"text":72,"@type":64},"RAC3 overexpression promoted proliferation of BIU-87-DDP cells, while RAC3 knockdown slowed cell growth and may affect JNK/MAPK pathway activation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337871,1791231384,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","DOI: 10. 1111/jcmm.18473  \nOR I G I NAL ART I C L E  \nUnveiling the role of RAC3 in the growth and invasion ofcisplatin-resistant bladder cancer cells  \nHaodong Li1  | Hongxuan Ma2 | JianHua Ma3 | Fei Qin1 | Siqi Fan1 | Shaopeng Kong1 | Sitao Zhao1 | Jianguo Ma1  \n1Department of Urology, Hebei Medical University Third Hospital, Shijiazhuang, China  \n2Faculty of Health and Behavioural Sciences, The University of Queensland, Queensland, Australia  \n3Geriatrics Department, Hebei Chengde Central Hospital, Chengde, China  \nCorrespondence  \nJianguo Ma, No. 139, Ziqiang Road, Qiaoxi, Shijiazhuang, Hebei 050051, China. [Email:](Email: mjg197103@163.com)[ mjg197103@163.com](Email: mjg197103@163.com)  \nFunding information  \nHebei Provincial Department of Science and Technology, Grant/Award Number:  \n2022180  \nAbstract  \nBladder cancer is one of the most prevalent cancers worldwide, and its morbidity and mortality rates have been increasing over the years. However, how RAC family small GTPase 3 (RAC3) affects the proliferation, migration and invasion of cisplatinresistant bladder cancer cells remains unclear. Bioinformatics techniques were used to investigate the expression of RAC3 in bladder cancer tissues. Influences of RAC3 in the grade, stage, distant metastasis, and survival rate of bladder cancer were also examined. Analysis of the relationship between RAC3 expression and the immune microenvironment (TIME), genomic mutations, and stemness index. In normal bladder cancer cells (T24, 5637, and BIU-87) and cisplatin-resistant bladder cancer cells (BIU-87-DDP), the expression of RAC3 was detected separately with Western blotting. Plasmid transfection was used to overexpress or silence the expression of RAC3 in bladder cancer cells resistant to cisplatin (BIU-87-DDP) . By adding activators and inhibitors, the activities of the JNK/MAPK signalling pathway were altered. Cell viability, invasion, and its level of apoptosis were measured in vitro using CCK-8, transwell, and flow cytometry. The bioinformatics analyses found RAC3 levels were elevated in bladder cancer tissues and were associated with a poor prognosis in bladder cancer. RAC3 in BIU-87-DDP cells expressed a higher level than normal bladder cancer cells. RAC3 overexpression promoted BIU-87-DDP proliferation. The growth of BIU-87-DDP cells slowed after the knockdown of RAC3, and RAC3 may have had an impact on the activation of the JNK/MAPK pathway.  \nK E Y WO R D S  \nbladder cancer, cisplatin resistance, invasion, JNK, proliferation, RAC3  \n1 | INTRODUCTION  \nBladder cancer is among the most common malignancies globally. With over 573,000 new cases diagnosed and over 213,000 fatalities  \nannually, the numbers are still continually increasing.1,2 Muscle invasive and metastasis occur in approximately 25% of patients with bladder cancer.3 Cisplatin-based neoadjuvant chemotherapy (NAC) improves the survival rate for patients with muscle invasive bladder  \n\n| Haodong Li and Hongxuan Ma have contributed equally to this work and share first authorship. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.\u003Cbr>© 2024 The Author(s) . Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. |\n\nJ Cell Mol Med. 2024;28:e18473 .  \n[https://doi.org/10.1111/jcmm.18473](https://doi.org/10.1111/jcmm.18473)  \n[wileyonlinelibrary.com/journal/jcmm](wileyonlinelibrary.com/journal/jcmm)  \n1 of 18  \ncancers who undergo radical cystectomies.4 However, only 35% of patients with metastatic bladder cancer react to cisplatin treatment at first. Most patients with pre-sensitive bladder cancer eventually develop resistance, which leads to poor patient prognoses allowing bladder cancer cells to continuously proliferate and metastasize.5 Therefore, to understand the specific mechanis","cbCaiacbkndSKrau","https://ap.wps.com/l/cbCaiacbkndSKrau","pdf",39473468,18,"English","# Abstract\n## Background and Rationale\n## Methods and Experimental Design\n## Key Findings","[{\"question\":\"Why is RAC3 investigated in cisplatin-resistant bladder cancer?\",\"answer\":\"RAC3 is a member of Rho GTPases known to influence cancer growth and drug resistance, but its specific regulatory role in cisplatin-resistant bladder cancer cells was previously unclear.\"},{\"question\":\"How was RAC3 expression analyzed in the study?\",\"answer\":\"Bioinformatics evaluated RAC3 expression in bladder cancer tissues, and Western blotting detected RAC3 levels in normal bladder cancer cell lines and the cisplatin-resistant BIU-87-DDP line.\"},{\"question\":\"What is the reported effect of altering RAC3 levels on cisplatin-resistant cells?\",\"answer\":\"RAC3 overexpression promoted proliferation of BIU-87-DDP cells, while RAC3 knockdown slowed cell growth and may affect JNK/MAPK pathway activation.\"}]","Unveiling the role of RAC3 in the growth and invasion of cisplatin-resistant bladder cancer cells - Abstract | PDF",1790021002,45,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/53ce1cb37e3bcc01051bc309d25015ed.webp",983,1291,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14466e67846b2470cdd32a35796ca975.webp",982,1290,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/57b725e25a9b6afb8dc9af0fe464fdb5.webp",981,1289,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/47e5ceca24a894114de9a5ab34a11052.webp",980,1287]